PubMed:27172902 / 1704-1942
Annnotations
LitCoin-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 0-238 | Sentence | denotes | Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells. |
LitCoin-entities
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
11319 | 41-50 | ChemicalEntity | denotes | cisplatin | MESH:D002945 |
11320 | 97-108 | ChemicalEntity | denotes | TLR agonist | |
11321 | 117-129 | DiseaseOrPhenotypicFeature | denotes | inflammatory | MESH:D007249 |
11322 | 154-159 | GeneOrGeneProduct | denotes | IL-10 | NCBIGene:16153 |
LitCoin_Mondo
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 59-77 | DiseaseOrPhenotypicFeature | denotes | immune-suppressive | 0007816 |
LitCoin-GeneOrGeneProduct-v0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T57 | 41-50 | GeneOrGeneProduct | denotes | cisplatin |
T58 | 51-58 | GeneOrGeneProduct | denotes | induces |
T59 | 59-65 | GeneOrGeneProduct | denotes | immune |
T60 | 109-116 | GeneOrGeneProduct | denotes | induced |
T61 | 154-159 | GeneOrGeneProduct | denotes | IL-10 |
T62 | 160-170 | GeneOrGeneProduct | denotes | production |
T63 | 191-211 | GeneOrGeneProduct | denotes | cell differentiation |
T64 | 228-231 | GeneOrGeneProduct | denotes | Tr1 |
T65 | 232-237 | GeneOrGeneProduct | denotes | cells |
LitCoin-GeneOrGeneProduct-v2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T32 | 41-50 | GeneOrGeneProduct | denotes | cisplatin |
T33 | 154-159 | GeneOrGeneProduct | denotes | IL-10 |
T34 | 191-211 | GeneOrGeneProduct | denotes | cell differentiation |
LitCoin-Disease-MeSH
Id | Subject | Object | Predicate | Lexical cue | originalLabel |
---|---|---|---|---|---|
T2 | 117-129 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
LitCoin-GeneOrGeneProduct-v3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T20 | 97-100 | GeneOrGeneProduct | denotes | TLR |
T21 | 154-159 | GeneOrGeneProduct | denotes | IL-10 |
LitCoin_Mondo_095
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T13 | 90-93 | DiseaseOrPhenotypicFeature | denotes | DCs | 0010155 |
LitCoin-MeSH-Disease-2
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T2 | 117-129 | DiseaseOrPhenotypicFeature | denotes | inflammatory | DISEASE |
LitCoin-Chemical-MeSH-CHEBI
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T24 | 41-50 | ChemicalEntity | denotes | cisplatin | D002945|http://purl.obolibrary.org/obo/CHEBI_27899 |
T26 | 97-108 | ChemicalEntity | denotes | TLR agonist | ChemicalEntity |
LitCoin-training-merged
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T26 | 97-108 | ChemicalEntity | denotes | TLR agonist | ChemicalEntity |
T24 | 41-50 | ChemicalEntity | denotes | cisplatin | http://purl.obolibrary.org/obo/CHEBI_27899|D002945 |
T21 | 154-159 | GeneOrGeneProduct | denotes | IL-10 | |
T20 | 97-100 | GeneOrGeneProduct | denotes | TLR |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 0-238 | Sentence | denotes | Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells. |
T9 | 0-238 | Sentence | denotes | Taken together, our results suggest that cisplatin induces immune-suppressive tolerogenic DCs in TLR agonist-induced inflammatory conditions via abundant IL-10 production, thereby skewing Th cell differentiation towards Th2 and Tr1 cells. |